Teva Stock Skids As First-Quarter Sales Decline — Again | Investor's Business Daily
Teva Pharmaceutical Industries Ltd. Fourth Quarter 2019 Results 2020-02-12¢ described in slide 29-30 - [PDF Document]
Teva Reports Fourth Quarter and Full Year 2020 Financial Results
Teva Pharmaceutical Industries (NYSE:TEVA) earnings and shareholder returns have been trending downwards for the last five years, but the stock lifts 3.6% this past week